Journey Clinical is on a mission to expand access to transformative, evidence-based psychedelic therapies, starting with Ketamine-Assisted Psychotherapy (KAP).
Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, gives the keynote address "Ketamine for Suicidal Depression: The Benefits...